Stock listing
Hanmi Pharmaceutical Co., Ltd.
Selected listing: 128940 · KRX · KRW · KR
Hanmi Pharmaceutical Co., Ltd. (KRX:128940), Health Technology. Latest release Sep 9, 2026: MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality…
- Ticker
- KRX:128940
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Hanmi Pharmaceutical Co., Ltd.
Hanmi Pharmaceutical Co., Ltd. is a publicly traded company on the Korean market, identified by the ticker 128940. Hanmi focuses on developing innovative pharmaceuticals and aims to enhance healthcare through its research and development efforts.
Latest news from Hanmi Pharmaceutical Co., Ltd.
MegazoneCloud Begins Building Hanmi Pharmaceutical's Quality Assurance AI Agent with 'AIR Studio'
September 8, 2026
Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights
March 31, 2026
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
March 19, 2026
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
March 13, 2026
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
February 24, 2026
Research Hanmi Pharmaceutical Co., Ltd.
Hanmi Pharmaceutical Co., Ltd. company profile
View the public company page for Hanmi Pharmaceutical Co., Ltd. on 6ix.
Hanmi Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Hanmi Pharmaceutical Co., Ltd..
Hanmi Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Hanmi Pharmaceutical Co., Ltd..